Current Ratio of Aprea Therapeutics, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aprea Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Aprea Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 591%, a 25% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Aprea Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 591% -202% -25% 30 Sep 2025
Q2 2025 642% -116% -15% 30 Jun 2025
Q1 2025 739% +29% +4.1% 31 Mar 2025
Q4 2024 863% +213% +33% 31 Dec 2024
Q3 2024 793% +44% +5.8% 30 Sep 2024
Q2 2024 758% -50% -6.2% 30 Jun 2024
Q1 2024 710% -2% -0.26% 31 Mar 2024
Q4 2023 650% -63% -8.8% 31 Dec 2023
Q3 2023 749% +47% +6.7% 30 Sep 2023
Q2 2023 808% +128% +19% 30 Jun 2023
Q1 2023 712% -1% -0.11% 31 Mar 2023
Q4 2022 713% +6% +0.81% 31 Dec 2022
Q3 2022 702% +40% +6% 30 Sep 2022
Q2 2022 680% -1% -0.13% 30 Jun 2022
Q1 2022 713% +2% +0.27% 31 Mar 2022
Q4 2021 708% -80% -10% 31 Dec 2021
Q3 2021 663% -310% -32% 30 Sep 2021
Q2 2021 681% -278% -29% 30 Jun 2021
Q1 2021 711% 31 Mar 2021
Q4 2020 788% 31 Dec 2020
Q3 2020 972% 30 Sep 2020
Q2 2020 959% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.